Italy· 045481013
INSULINA LISPRO*5 cartucce SC 300 U 3 ml
A medicinal product containing insulina lispro da dna ricombinante, registered in Italy by SANOFI-AVENTIS GROUPE, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Insulina lispro da DNA ricombinante
- Manufacturer
- SANOFI-AVENTIS GROUPE
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic045481013INSULINA LISPRO*5 cartucce SC 300 U 3 mlEUR 37.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulina lispro da dna ricombinante in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAdmelog 100units/ml solution for injection 10ml vialsSanofi
- CzechiaBYSUMLOGGan & Lee Pharmaceuticals Europe GmbH, Düsseldorf
- United StatesADMELOGSanofi-Aventis U.S. LLC
- FinlandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- BelgiumBysumlog 100 U/mlGan & Lee Pharmaceuticals Europe
- SwedenBysumlog 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaSandoz GmbH
- IcelandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- NetherlandsBysumlog 100 eenheden/ml oplossing voor injectie in een voorgevulde penGan & Lee Pharmaceuticals Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bysumlog, Humalog
- Liechtenstein · Bysumlog, Humalog
- Norway · Bysumlog, Humalog
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02ed0cc0-7a7e-48a8-8df1-7e64899875f8 GET /v1/drugs/02ed0cc0-7a7e-48a8-8df1-7e64899875f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 37.3,
"source": "aifa",
"currency": "EUR",
"strength": "INSULINA LISPRO DA DNA RICOMBINANTE 300U 3ML 5 UNITA' USO PARENTERALE",
"substance": "Insulina lispro da DNA ricombinante",
"equivalence_group": "N6B",
"transparency_flag": null
}See everything about insulina lispro da dna ricombinante.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.